These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32246177)

  • 41. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
    Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A
    Mult Scler; 2014 Mar; 20(3):356-64. PubMed ID: 23959709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum.
    Audoin B; Ibarrola D; Malikova I; Soulier E; Confort-Gouny S; Duong MV; Reuter F; Viout P; Ali-Chérif A; Cozzone PJ; Pelletier J; Ranjeva JP
    Mult Scler; 2007 Jan; 13(1):41-51. PubMed ID: 17294610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study.
    Horakova D; Cox JL; Havrdova E; Hussein S; Dolezal O; Cookfair D; Dwyer MG; Seidl Z; Bergsland N; Vaneckova M; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):407-14. PubMed ID: 17550987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurements of the corpus callosum index and fractional anisotropy of the corpus callosum and their cutoff values are useful to assess global brain volume loss in multiple sclerosis.
    Fujimori J; Uryu K; Fujihara K; Wattjes MP; Suzuki C; Nakashima I
    Mult Scler Relat Disord; 2020 Oct; 45():102388. PubMed ID: 32659734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
    Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients.
    Kalinowska-Lyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Bus K; Leszczynski P; Puszczewicz M; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Sep; 27(10):1624-1635. PubMed ID: 29950159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRI analysis of brain atrophy after severe closed-head injury: relation to clinical status.
    Henry-Feugeas MC; Azouvi P; Fontaine A; Denys P; Bussel B; Maaz F; Samson Y; Schouman-Claeys E
    Brain Inj; 2000 Jul; 14(7):597-604. PubMed ID: 10914642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brain atrophy as a marker of cognitive impairment in mildly disabling relapsing-remitting multiple sclerosis.
    Sánchez MP; Nieto A; Barroso J; Martín V; Hernández MA
    Eur J Neurol; 2008 Oct; 15(10):1091-9. PubMed ID: 18727673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls.
    Alvarez E; Nair KV; Hoyt BD; Seale RA; Sillau S; Miravalle A; Engebretson E; Schurr B; Corboy JR; Vollmer TL; Honce JM
    Mult Scler Relat Disord; 2021 Oct; 55():103170. PubMed ID: 34364034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
    Uher T; Vaneckova M; Krasensky J; Sobisek L; Tyblova M; Volna J; Seidl Z; Bergsland N; Dwyer MG; Zivadinov R; De Stefano N; Sormani MP; Havrdova EK; Horakova D
    Mult Scler; 2019 Apr; 25(4):541-553. PubMed ID: 29143562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.
    Sampat MP; Berger AM; Healy BC; Hildenbrand P; Vass J; Meier DS; Chitnis T; Weiner HL; Bakshi R; Guttmann CR
    AJNR Am J Neuroradiol; 2009 Oct; 30(9):1731-9. PubMed ID: 19696139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
    Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
    Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosis.
    Hemond CC; Chu R; Tummala S; Tauhid S; Healy BC; Bakshi R
    Brain Behav; 2018 Aug; 8(8):e01068. PubMed ID: 30019857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.
    Sinnecker T; Ruberte E; Schädelin S; Canova V; Amann M; Naegelin Y; Penner IK; Müller J; Kuhle J; Décard B; Derfuss T; Kappos L; Granziera C; Wuerfel J; Magon S; Yaldizli Ö
    J Neurol; 2020 Jan; 267(1):192-202. PubMed ID: 31612322
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
    Uher T; Vaneckova M; Sobisek L; Tyblova M; Seidl Z; Krasensky J; Ramasamy D; Zivadinov R; Havrdova E; Kalincik T; Horakova D
    Mult Scler; 2017 Jan; 23(1):51-61. PubMed ID: 27053635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction of Cerebral and Corpus Callosum Volumes in Childhood-Onset Systemic Lupus Erythematosus: A Volumetric Magnetic Resonance Imaging Analysis.
    Tamires Lapa A; Postal M; Angélica Sinicato N; Geraldo Ferreira W; Siqueira Bellini B; Teixeira Fernandes P; Rittner L; Marini R; Cendes F; Appenzeller S
    Arthritis Rheumatol; 2016 Sep; 68(9):2193-9. PubMed ID: 26991912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.
    Rudick RA; Fisher E; Lee JC; Duda JT; Simon J
    Mult Scler; 2000 Dec; 6(6):365-72. PubMed ID: 11212130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis.
    Figueira FF; Santos VS; Figueira GM; Silva AC
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):931-5. PubMed ID: 18094848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corpus callosum axon diameter relates to cognitive impairment in multiple sclerosis.
    Huang SY; Fan Q; Machado N; Eloyan A; Bireley JD; Russo AW; Tobyne SM; Patel KR; Brewer K; Rapaport SF; Nummenmaa A; Witzel T; Sherman JC; Wald LL; Klawiter EC
    Ann Clin Transl Neurol; 2019 May; 6(5):882-892. PubMed ID: 31139686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.